Neuroblastoma: biology and molecular and chromosomal pathology (Q35193677)

7 August 2017

1 reference

title

Neuroblastoma: biology and molecular and chromosomal pathology (English)

1 reference

7 August 2017

0 references

1 reference

Manfred Schwab

1

1 reference

7 August 2017

Frank Westermann

series ordinal

2

1 reference

7 August 2017

Barbara Hero

series ordinal

3

1 reference

7 August 2017

Frank Berthold

series ordinal

4

1 reference

7 August 2017

1 August 2003

1 reference

Lancet Oncology Commission

7 August 2017

1 reference

7 August 2017

4

1 reference

7 August 2017

8

1 reference

7 August 2017

472-480

1 reference

Why does stage 4s neuroblastoma regress spontaneously?

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Spontaneous regression of stage IV neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Prolonged survival of a patient with disseminated neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Neuroblastoma: current drug therapy recommendations as part of the total treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Amplification of a DEAD box protein gene in retinoblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Nucleotide sequence of the human N-myc gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Human proto-oncogene N-myc encodes nuclear proteins that bind DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

DNA amplification at 11q13 in human cancer: from complexity to perplexity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

A role for common fragile site induction in amplification of human oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Experience with International Neuroblastoma Staging System and Pathology Classification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

A Polymorphic Genomic Duplication on Human Chromosome 15 Is a Susceptibility Factor for Panic and Phobic Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Molecular analysis of chromosome arm 17q gain in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Allelic imbalance on chromosome 18 in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: evidence for two deleted regions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Genetic parameters of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Genomic instability in 1p and human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Loss of chromosome 1p may have a prognostic value in localised Neuroblastoma: results of the French NBL 90 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Functions of the neurotrophins during nervous system development: what the knockouts are teaching us.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Role of neurotrophins in mouse neuronal development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Trk receptor tyrosine kinases: a bridge between cancer and neural development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Expression and function of TRK-B and BDNF in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Expression and function of Trk-C in favourable human neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Comprehensive analysis of chromosome 1p deletions in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

Detailed molecular analysis of 1p36 in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901166-5

7 January 2021

10.1016/S1470-2045(03)01166-5

Identifiers

DOI

1 reference

7 August 2017

1 reference